Preserve Access to Affordable Generics and Biosimilars Act

Read twice and referred to the Committee on the Judiciary.

Congressional Research Service

Official summary

Version 00 · Introduced in Senate · Dec 19, 2018

Preserve Access to Affordable Generics and Biosimilars Act

This bill amends the Federal Trade Commission Act to authorize the Federal Trade Commission to initiate proceedings against parties to any agreement resolving or settling a patent infringement claim in connection with the sale of a drug or biological product. Such an agreement, with specified exceptions, is presumed to have anticompetitive effects and violates this bill if the filer of an abbreviated new drug (generic) application or a biosimilar biological product application: (1) receives anything of value; and (2) agrees to limit or forego research, development, manufacturing, marketing, or sales of the generic drug or biosimilar biological product for any period of time.

Read the summary on Congress.gov

PlainBill analysis is coming later. This page presents official source data. We have not yet published a PlainBill explanation for this bill.

People & committees

Who introduced it

Sen. Klobuchar, Amy [D-MN] · D–MN

Committees

Judiciary Committee

1 cosponsorship records, including any withdrawals

Sen. Grassley, Chuck [R-IA]

Legislative record

Actions

A procedural vote is different from passage. Passage in one chamber does not establish enactment. Explore the glossary.

Dec 19, 2018
Read twice and referred to the Committee on the Judiciary.
Dec 19, 2018
Introduced in Senate

Primary sources

Bill text & related measures

Text links open the official source. We currently store references to these documents.

Introduced in Senate · Dec 19, 2018 Formatted Text PDF Formatted XML

Related bills identified by Congress.gov

S 124 · Preserve Access to Affordable Generics Act

Source last updated: Aug 10, 2026. Consult Congress.gov for the current record.

AI Conversation Starters

Explore the bill from different angles

Choose a perspective, copy a prompt, and paste it into your preferred AI. Each prompt includes the bill version and available official source links, and asks for counterarguments as well as supporting evidence.

Neutral evidence review

Objective

Analyze S.3792 as objectively as possible. Explain its main provisions, who would be affected, possible benefits and harms, implementation, exceptions, and uncertainties. Present the strongest arguments for and against it, and identify evidence needed to assess its public impact.

View full prompt & sources

Discuss S.3792, 115th Congress: Preserve Access to Affordable Generics and Biosimilars Act

Official record: https://www.congress.gov/bill/115th-congress/senate-bill/3792

Text version to examine: Introduced in Senate · 2018-12-19.

Official full text: https://www.congress.gov/115/bills/s3792/BILLS-115s3792is.htm

Imported record last updated by the source: 2026-08-10T11:51:27Z. Verify current status and distinguish any later version from the version above.

Read the official text before answering. If you cannot access it, say so and ask me to provide it; do not assume a link means you have read the document. Distinguish proposals from enacted law, cite sources, and separate facts, interpretation, and uncertain predictions. Include counterarguments even when using a particular perspective.

Analyze S.3792 as objectively as possible. Explain its main provisions, who would be affected, possible benefits and harms, implementation, exceptions, and uncertainties. Present the strongest arguments for and against it, and identify evidence needed to assess its public impact.

Fairness and public impact

Progressive lens

Examine S.3792 through a progressive lens, focusing on fairness, access, economic inequality, and effects on vulnerable communities. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and distinguish stated goals from demonstrated outcomes.

View full prompt & sources

Discuss S.3792, 115th Congress: Preserve Access to Affordable Generics and Biosimilars Act

Official record: https://www.congress.gov/bill/115th-congress/senate-bill/3792

Text version to examine: Introduced in Senate · 2018-12-19.

Official full text: https://www.congress.gov/115/bills/s3792/BILLS-115s3792is.htm

Imported record last updated by the source: 2026-08-10T11:51:27Z. Verify current status and distinguish any later version from the version above.

Read the official text before answering. If you cannot access it, say so and ask me to provide it; do not assume a link means you have read the document. Distinguish proposals from enacted law, cite sources, and separate facts, interpretation, and uncertain predictions. Include counterarguments even when using a particular perspective.

Examine S.3792 through a progressive lens, focusing on fairness, access, economic inequality, and effects on vulnerable communities. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and distinguish stated goals from demonstrated outcomes.

Institutions and government scope

Conservative lens

Examine S.3792 through a conservative lens, focusing on fiscal responsibility, institutional stability, federalism, and the scope of government. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and any provisions that challenge this perspective.

View full prompt & sources

Discuss S.3792, 115th Congress: Preserve Access to Affordable Generics and Biosimilars Act

Official record: https://www.congress.gov/bill/115th-congress/senate-bill/3792

Text version to examine: Introduced in Senate · 2018-12-19.

Official full text: https://www.congress.gov/115/bills/s3792/BILLS-115s3792is.htm

Imported record last updated by the source: 2026-08-10T11:51:27Z. Verify current status and distinguish any later version from the version above.

Read the official text before answering. If you cannot access it, say so and ask me to provide it; do not assume a link means you have read the document. Distinguish proposals from enacted law, cite sources, and separate facts, interpretation, and uncertain predictions. Include counterarguments even when using a particular perspective.

Examine S.3792 through a conservative lens, focusing on fiscal responsibility, institutional stability, federalism, and the scope of government. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and any provisions that challenge this perspective.

Individual rights and government power

Liberty lens

Examine S.3792 through a civil-liberties and limited-government lens. Consider individual rights, privacy, voluntary choice, accountability, and government power. Explain tradeoffs, possible safeguards, and the strongest counterarguments without assuming the proposal is beneficial or harmful.

View full prompt & sources

Discuss S.3792, 115th Congress: Preserve Access to Affordable Generics and Biosimilars Act

Official record: https://www.congress.gov/bill/115th-congress/senate-bill/3792

Text version to examine: Introduced in Senate · 2018-12-19.

Official full text: https://www.congress.gov/115/bills/s3792/BILLS-115s3792is.htm

Imported record last updated by the source: 2026-08-10T11:51:27Z. Verify current status and distinguish any later version from the version above.

Read the official text before answering. If you cannot access it, say so and ask me to provide it; do not assume a link means you have read the document. Distinguish proposals from enacted law, cite sources, and separate facts, interpretation, and uncertain predictions. Include counterarguments even when using a particular perspective.

Examine S.3792 through a civil-liberties and limited-government lens. Consider individual rights, privacy, voluntary choice, accountability, and government power. Explain tradeoffs, possible safeguards, and the strongest counterarguments without assuming the proposal is beneficial or harmful.